APO Research

APO RESEARCH · REPORT

Genome Sequencing Service

Selected research

Market Analysis & Forecast

Global Genome Sequencing Service Market Analysis and Forecast 2026-2032

Market perspective

The global Genome Sequencing Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Genome Sequencing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Genome Sequencing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Genome Sequencing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Genome Sequencing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Genome Sequencing Service include Illumina, Thermo Fisher Scientific, BGI Genomics, Agilent Technologies, CD Genomics, Azenta Life Sciences, Broad Clinical Labs, Macrogen and GE Healthcare Life Sciences, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Genome Sequencing Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Genome Sequencing Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Genome Sequencing Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Genome Sequencing Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Genome Sequencing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Genome Sequencing Service revenue, projected growth trends, production technology, application and end-user industry.

Genome Sequencing Service Segment by Company

Illumina

Thermo Fisher Scientific

BGI Genomics

Agilent Technologies

CD Genomics

Azenta Life Sciences

Broad Clinical Labs

Macrogen

GE Healthcare Life Sciences

Johnson & Johnson

Abbott Laboratories

Bayer

Microchip Biotechnologies

GeneDx

Commonwealth Biotechnologies

ZS Genetics

Pacific Biosciences

Novogene

Eurofins Genomics

Psomagen

Genome Sequencing Service Segment by Type

Whole-Genome Sequencing

Whole exome Sequencing

Others

Genome Sequencing Service Segment by Application

Humanity

Plant

Animal

Microorganism

Virus

Genome Sequencing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genome Sequencing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Genome Sequencing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genome Sequencing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Genome Sequencing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Genome Sequencing Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Genome Sequencing Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Genome Sequencing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Whole-Genome Sequencing Major Player Table 3. Whole exome Sequencing Major Player Table 4. Others Major Player Table 5. Global Genome Sequencing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Humanity Major Player Table 7. Plant Major Player Table 8. Animal Major Player Table 9. Microorganism Major Player Table 10. Virus Major Player Table 11. Genome Sequencing Service Industry Trends Table 12. Genome Sequencing Service Industry Drivers Table 13. Genome Sequencing Service Industry Opportunities and Challenges Table 14. Genome Sequencing Service Industry Restraints Table 15. Global Genome Sequencing Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Genome Sequencing Service Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Genome Sequencing Service Market Share by Region (2021-2026) Table 18. Global Genome Sequencing Service Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Genome Sequencing Service Market Share by Region (2027-2032) Table 20. Global Genome Sequencing Service Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Genome Sequencing Service Revenue Market Share by Players (2021-2026) Table 22. Global Genome Sequencing Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Genome Sequencing Service Key Players Headquarters & Area Served Table 24. Global Genome Sequencing Service Players, Product Type & Application Table 25. Global Genome Sequencing Service Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Genome Sequencing Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Genome Sequencing Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Genome Sequencing Service Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Genome Sequencing Service Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Genome Sequencing Service Revenue Market Share by Type (2021-2026) Table 32. Global Genome Sequencing Service Revenue Market Share by Type (2027-2032) Table 33. Global Genome Sequencing Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Genome Sequencing Service Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Genome Sequencing Service Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Genome Sequencing Service Revenue Market Share by Application (2021-2026) Table 37. Global Genome Sequencing Service Revenue Market Share by Application (2027-2032) Table 38. Illumina Company Information Table 39. Illumina Business Overview Table 40. Illumina Genome Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Illumina Genome Sequencing Service Product Portfolio Table 42. Illumina Recent Development Table 43. Thermo Fisher Scientific Company Information Table 44. Thermo Fisher Scientific Business Overview Table 45. Thermo Fisher Scientific Genome Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Thermo Fisher Scientific Genome Sequencing Service Product Portfolio Table 47. Thermo Fisher Scientific Recent Development Table 48. BGI Genomics Company Information Table 49. BGI Genomics Business Overview Table 50. BGI Genomics Genome Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. BGI Genomics Genome Sequencing Service Product Portfolio Table 52. BGI Genomics Recent Development Table 53. Agilent Technologies Company Information Table 54. Agilent Technologies Business Overview Table 55. Agilent Technologies Genome Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Agilent Technologies Genome Sequencing Service Product Portfolio Table 57. Agilent Technologies Recent Development Table 58. CD Genomics Company Information Table 59. CD Genomics Business Overview Table 60. CD Genomics Genome Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. CD Genomics Genome Sequencing Service Product Portfolio Table 62. CD Genomics Recent Development Table 63. Azenta Life Sciences Company Information Table 64. Azenta Life Sciences Business Overview Table 65. Azenta Life Sciences Genome Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Azenta Life Sciences Genome Sequencing Service Product Portfolio Table 67. Azenta Life Sciences Recent Development Table 68. Broad Clinical Labs Company Information Table 69. Broad Clinical Labs Business Overview Table 70. Broad Clinical Labs Genome Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Broad Clinical Labs Genome Sequencing Service Product Portfolio Table 72. Broad Clinical Labs Recent Development Table 73. Macrogen Company Information Table 74. Macrogen Business Overview Table 75. Macrogen Genome Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Macrogen Genome Sequencing Service Product Portfolio Table 77. Macrogen Recent Development Table 78. GE Healthcare Life Sciences Company Information Table 79. GE Healthcare Life Sciences Business Overview Table 80. GE Healthcare Life Sciences Genome Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. GE Healthcare Life Sciences Genome Sequencing Service Product Portfolio Table 82. GE Healthcare Life Sciences Recent Development Table 83. Johnson & Johnson Company Information Table 84. Johnson & Johnson Business Overview Table 85. Johnson & Johnson Genome Sequencing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Johnson & Johnson Genome Sequencing Service Product Portfolio Table 87. Johnson & Johnson Recent Development Table 88. Abbott Laboratories Company Information Table 89. Abbott Laboratories Business Overview Table 90. Abbott Laboratories Genome Sequencing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Abbott Laboratories Genome Sequencing Service Product Portfolio Table 92. Abbott Laboratories Recent Development Table 93. Bayer Company Information Table 94. Bayer Business Overview Table 95. Bayer Genome Sequencing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Bayer Genome Sequencing Service Product Portfolio Table 97. Bayer Recent Development Table 98. Microchip Biotechnologies Company Information Table 99. Microchip Biotechnologies Business Overview Table 100. Microchip Biotechnologies Genome Sequencing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Microchip Biotechnologies Genome Sequencing Service Product Portfolio Table 102. Microchip Biotechnologies Recent Development Table 103. GeneDx Company Information Table 104. GeneDx Business Overview Table 105. GeneDx Genome Sequencing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. GeneDx Genome Sequencing Service Product Portfolio Table 107. GeneDx Recent Development Table 108. Commonwealth Biotechnologies Company Information Table 109. Commonwealth Biotechnologies Business Overview Table 110. Commonwealth Biotechnologies Genome Sequencing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Commonwealth Biotechnologies Genome Sequencing Service Product Portfolio Table 112. Commonwealth Biotechnologies Recent Development Table 113. ZS Genetics Company Information Table 114. ZS Genetics Business Overview Table 115. ZS Genetics Genome Sequencing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. ZS Genetics Genome Sequencing Service Product Portfolio Table 117. ZS Genetics Recent Development Table 118. Pacific Biosciences Company Information Table 119. Pacific Biosciences Business Overview Table 120. Pacific Biosciences Genome Sequencing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Pacific Biosciences Genome Sequencing Service Product Portfolio Table 122. Pacific Biosciences Recent Development Table 123. Novogene Company Information Table 124. Novogene Business Overview Table 125. Novogene Genome Sequencing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Novogene Genome Sequencing Service Product Portfolio Table 127. Novogene Recent Development Table 128. Eurofins Genomics Company Information Table 129. Eurofins Genomics Business Overview Table 130. Eurofins Genomics Genome Sequencing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Eurofins Genomics Genome Sequencing Service Product Portfolio Table 132. Eurofins Genomics Recent Development Table 133. Psomagen Company Information Table 134. Psomagen Business Overview Table 135. Psomagen Genome Sequencing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. Psomagen Genome Sequencing Service Product Portfolio Table 137. Psomagen Recent Development Table 138. North America Genome Sequencing Service Revenue by Type (2021-2026) & (US$ Million) Table 139. North America Genome Sequencing Service Revenue by Type (2027-2032) & (US$ Million) Table 140. North America Genome Sequencing Service Revenue by Application (2021-2026) & (US$ Million) Table 141. North America Genome Sequencing Service Revenue by Application (2027-2032) & (US$ Million) Table 142. North America Genome Sequencing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. North America Genome Sequencing Service Revenue by Country (2021-2026) & (US$ Million) Table 144. North America Genome Sequencing Service Revenue by Country (US$ Million) & (2027-2032) Table 145. Europe Genome Sequencing Service Revenue by Type (2021-2026) & (US$ Million) Table 146. Europe Genome Sequencing Service Revenue by Type (2027-2032) & (US$ Million) Table 147. Europe Genome Sequencing Service Revenue by Application (2021-2026) & (US$ Million) Table 148. Europe Genome Sequencing Service Revenue by Application (2027-2032) & (US$ Million) Table 149. Europe Genome Sequencing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Europe Genome Sequencing Service Revenue by Country (2021-2026) & (US$ Million) Table 151. Europe Genome Sequencing Service Revenue by Country (US$ Million) & (2027-2032) Table 152. China Genome Sequencing Service Revenue by Type (2021-2026) & (US$ Million) Table 153. China Genome Sequencing Service Revenue by Type (2027-2032) & (US$ Million) Table 154. China Genome Sequencing Service Revenue by Application (2021-2026) & (US$ Million) Table 155. China Genome Sequencing Service Revenue by Application (2027-2032) & (US$ Million) Table 156. Asia Genome Sequencing Service Revenue by Type (2021-2026) & (US$ Million) Table 157. Asia Genome Sequencing Service Revenue by Type (2027-2032) & (US$ Million) Table 158. Asia Genome Sequencing Service Revenue by Application (2021-2026) & (US$ Million) Table 159. Asia Genome Sequencing Service Revenue by Application (2027-2032) & (US$ Million) Table 160. Asia Genome Sequencing Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 161. Asia Genome Sequencing Service Revenue by Region (US$ Million) & (2021-2026) Table 162. Asia Genome Sequencing Service Revenue by Region (US$ Million) & (2027-2032) Table 163. SAMEA Genome Sequencing Service Revenue by Type (2021-2026) & (US$ Million) Table 164. SAMEA Genome Sequencing Service Revenue by Type (2027-2032) & (US$ Million) Table 165. SAMEA Genome Sequencing Service Revenue by Application (2021-2026) & (US$ Million) Table 166. SAMEA Genome Sequencing Service Revenue by Application (2027-2032) & (US$ Million) Table 167. SAMEA Genome Sequencing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 168. SAMEA Genome Sequencing Service Revenue by Country (2021-2026) & (US$ Million) Table 169. SAMEA Genome Sequencing Service Revenue by Country (US$ Million) & (2027-2032) Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Genome Sequencing Service Image Figure 2. Global Genome Sequencing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Genome Sequencing Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Whole-Genome Sequencing Image Figure 5. Whole exome Sequencing Image Figure 6. Others Image Figure 7. Global Genome Sequencing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Genome Sequencing Service Market Size Share 2021 VS 2025 VS 2032 Figure 9. Humanity Image Figure 10. Plant Image Figure 11. Animal Image Figure 12. Microorganism Image Figure 13. Virus Image Figure 14. Global Genome Sequencing Service Market Size (US$ Million) & (2021-2032) Figure 15. Global Genome Sequencing Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Genome Sequencing Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Genome Sequencing Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Genome Sequencing Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Genome Sequencing Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Genome Sequencing Service Revenue Market Share by Type (2021-2032) Figure 22. Global Genome Sequencing Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Genome Sequencing Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Genome Sequencing Service Revenue Market Share by Application (2021-2032) Figure 25. North America Genome Sequencing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Genome Sequencing Service Revenue Share by Type (2021-2032) Figure 27. North America Genome Sequencing Service Revenue Share by Application (2021-2032) Figure 28. North America Genome Sequencing Service Revenue Share by Country (2021-2032) Figure 29. United States Genome Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Genome Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Genome Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Genome Sequencing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Genome Sequencing Service Revenue Share by Type (2021-2032) Figure 34. Europe Genome Sequencing Service Revenue Share by Application (2021-2032) Figure 35. Europe Genome Sequencing Service Revenue Share by Country (2021-2032) Figure 36. Germany Genome Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Genome Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Genome Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Genome Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Genome Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Genome Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Genome Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Genome Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Genome Sequencing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Genome Sequencing Service Revenue Share by Type (2021-2032) Figure 46. China Genome Sequencing Service Revenue Share by Application (2021-2032) Figure 47. Asia Genome Sequencing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Genome Sequencing Service Revenue Share by Type (2021-2032) Figure 49. Asia Genome Sequencing Service Revenue Share by Application (2021-2032) Figure 50. Asia Genome Sequencing Service Revenue Share by Region (2021-2032) Figure 51. Japan Genome Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Genome Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Genome Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Genome Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Genome Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Genome Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Genome Sequencing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Genome Sequencing Service Revenue Share by Type (2021-2032) Figure 59. SAMEA Genome Sequencing Service Revenue Share by Application (2021-2032) Figure 60. SAMEA Genome Sequencing Service Revenue Share by Country (2021-2032) Figure 61. Brazil Genome Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Genome Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Genome Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Genome Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Genome Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Genome Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Genome Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Genome Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Genome Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Genome Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Genome Sequencing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Whole-Genome Sequencing
  • Whole exome Sequencing
  • Others
Applications
  • Humanity
  • Plant
  • Animal
  • Microorganism
  • Virus
Companies covered
  • Illumina
  • Thermo Fisher Scientific
  • BGI Genomics
  • Agilent Technologies
  • CD Genomics
  • Azenta Life Sciences
  • Broad Clinical Labs
  • Macrogen
  • GE Healthcare Life Sciences
  • Johnson & Johnson
  • Abbott Laboratories
  • Bayer
  • Microchip Biotechnologies
  • GeneDx
  • Commonwealth Biotechnologies
  • ZS Genetics
  • Pacific Biosciences
  • Novogene
  • Eurofins Genomics
  • Psomagen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Genome Sequencing Service Market by Type
  3. 1.2.1 Global Genome Sequencing Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Whole-Genome Sequencing
  5. 1.2.3 Whole exome Sequencing
  6. 1.2.4 Others
  7. 1.3 Genome Sequencing Service Market by Application
  8. 1.3.1 Global Genome Sequencing Service Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Humanity
  10. 1.3.3 Plant
  11. 1.3.4 Animal
  12. 1.3.5 Microorganism
  13. 1.3.6 Virus
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Genome Sequencing Service Market Dynamics
  1. 2.1 Genome Sequencing Service Industry Trends
  2. 2.2 Genome Sequencing Service Industry Drivers
  3. 2.3 Genome Sequencing Service Industry Opportunities and Challenges
  4. 2.4 Genome Sequencing Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Genome Sequencing Service Market Perspective (2021-2032)
  2. 3.2 Global Genome Sequencing Service Growth Trends by Region
  3. 3.2.1 Global Genome Sequencing Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Genome Sequencing Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Genome Sequencing Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Genome Sequencing Service Revenue by Players
  2. 4.1.1 Global Genome Sequencing Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Genome Sequencing Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Genome Sequencing Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Genome Sequencing Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Genome Sequencing Service Key Players Headquarters & Area Served
  7. 4.4 Global Genome Sequencing Service Players, Product Type & Application
  8. 4.5 Global Genome Sequencing Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Genome Sequencing Service Market CR5 and HHI
  11. 4.6.3 2025 Genome Sequencing Service Tier 1, Tier 2, and Tier 3
5 Genome Sequencing Service Market Size by Type
  1. 5.1 Global Genome Sequencing Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Genome Sequencing Service Revenue by Type (2021-2032)
  3. 5.3 Global Genome Sequencing Service Revenue Market Share by Type (2021-2032)
6 Genome Sequencing Service Market Size by Application
  1. 6.1 Global Genome Sequencing Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Genome Sequencing Service Revenue by Application (2021-2032)
  3. 6.3 Global Genome Sequencing Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Illumina
  2. 7.1.1 Illumina Company Information
  3. 7.1.2 Illumina Business Overview
  4. 7.1.3 Illumina Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Illumina Genome Sequencing Service Product Portfolio
  6. 7.1.5 Illumina Recent Developments
  7. 7.2 Thermo Fisher Scientific
  8. 7.2.1 Thermo Fisher Scientific Company Information
  9. 7.2.2 Thermo Fisher Scientific Business Overview
  10. 7.2.3 Thermo Fisher Scientific Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Thermo Fisher Scientific Genome Sequencing Service Product Portfolio
  12. 7.2.5 Thermo Fisher Scientific Recent Developments
  13. 7.3 BGI Genomics
  14. 7.3.1 BGI Genomics Company Information
  15. 7.3.2 BGI Genomics Business Overview
  16. 7.3.3 BGI Genomics Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 BGI Genomics Genome Sequencing Service Product Portfolio
  18. 7.3.5 BGI Genomics Recent Developments
  19. 7.4 Agilent Technologies
  20. 7.4.1 Agilent Technologies Company Information
  21. 7.4.2 Agilent Technologies Business Overview
  22. 7.4.3 Agilent Technologies Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Agilent Technologies Genome Sequencing Service Product Portfolio
  24. 7.4.5 Agilent Technologies Recent Developments
  25. 7.5 CD Genomics
  26. 7.5.1 CD Genomics Company Information
  27. 7.5.2 CD Genomics Business Overview
  28. 7.5.3 CD Genomics Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 CD Genomics Genome Sequencing Service Product Portfolio
  30. 7.5.5 CD Genomics Recent Developments
  31. 7.6 Azenta Life Sciences
  32. 7.6.1 Azenta Life Sciences Company Information
  33. 7.6.2 Azenta Life Sciences Business Overview
  34. 7.6.3 Azenta Life Sciences Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Azenta Life Sciences Genome Sequencing Service Product Portfolio
  36. 7.6.5 Azenta Life Sciences Recent Developments
  37. 7.7 Broad Clinical Labs
  38. 7.7.1 Broad Clinical Labs Company Information
  39. 7.7.2 Broad Clinical Labs Business Overview
  40. 7.7.3 Broad Clinical Labs Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Broad Clinical Labs Genome Sequencing Service Product Portfolio
  42. 7.7.5 Broad Clinical Labs Recent Developments
  43. 7.8 Macrogen
  44. 7.8.1 Macrogen Company Information
  45. 7.8.2 Macrogen Business Overview
  46. 7.8.3 Macrogen Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Macrogen Genome Sequencing Service Product Portfolio
  48. 7.8.5 Macrogen Recent Developments
  49. 7.9 GE Healthcare Life Sciences
  50. 7.9.1 GE Healthcare Life Sciences Company Information
  51. 7.9.2 GE Healthcare Life Sciences Business Overview
  52. 7.9.3 GE Healthcare Life Sciences Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 GE Healthcare Life Sciences Genome Sequencing Service Product Portfolio
  54. 7.9.5 GE Healthcare Life Sciences Recent Developments
  55. 7.10 Johnson & Johnson
  56. 7.10.1 Johnson & Johnson Company Information
  57. 7.10.2 Johnson & Johnson Business Overview
  58. 7.10.3 Johnson & Johnson Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Johnson & Johnson Genome Sequencing Service Product Portfolio
  60. 7.10.5 Johnson & Johnson Recent Developments
  61. 7.11 Abbott Laboratories
  62. 7.11.1 Abbott Laboratories Company Information
  63. 7.11.2 Abbott Laboratories Business Overview
  64. 7.11.3 Abbott Laboratories Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Abbott Laboratories Genome Sequencing Service Product Portfolio
  66. 7.11.5 Abbott Laboratories Recent Developments
  67. 7.12 Bayer
  68. 7.12.1 Bayer Company Information
  69. 7.12.2 Bayer Business Overview
  70. 7.12.3 Bayer Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Bayer Genome Sequencing Service Product Portfolio
  72. 7.12.5 Bayer Recent Developments
  73. 7.13 Microchip Biotechnologies
  74. 7.13.1 Microchip Biotechnologies Company Information
  75. 7.13.2 Microchip Biotechnologies Business Overview
  76. 7.13.3 Microchip Biotechnologies Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Microchip Biotechnologies Genome Sequencing Service Product Portfolio
  78. 7.13.5 Microchip Biotechnologies Recent Developments
  79. 7.14 GeneDx
  80. 7.14.1 GeneDx Company Information
  81. 7.14.2 GeneDx Business Overview
  82. 7.14.3 GeneDx Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 GeneDx Genome Sequencing Service Product Portfolio
  84. 7.14.5 GeneDx Recent Developments
  85. 7.15 Commonwealth Biotechnologies
  86. 7.15.1 Commonwealth Biotechnologies Company Information
  87. 7.15.2 Commonwealth Biotechnologies Business Overview
  88. 7.15.3 Commonwealth Biotechnologies Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Commonwealth Biotechnologies Genome Sequencing Service Product Portfolio
  90. 7.15.5 Commonwealth Biotechnologies Recent Developments
  91. 7.16 ZS Genetics
  92. 7.16.1 ZS Genetics Company Information
  93. 7.16.2 ZS Genetics Business Overview
  94. 7.16.3 ZS Genetics Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 ZS Genetics Genome Sequencing Service Product Portfolio
  96. 7.16.5 ZS Genetics Recent Developments
  97. 7.17 Pacific Biosciences
  98. 7.17.1 Pacific Biosciences Company Information
  99. 7.17.2 Pacific Biosciences Business Overview
  100. 7.17.3 Pacific Biosciences Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Pacific Biosciences Genome Sequencing Service Product Portfolio
  102. 7.17.5 Pacific Biosciences Recent Developments
  103. 7.18 Novogene
  104. 7.18.1 Novogene Company Information
  105. 7.18.2 Novogene Business Overview
  106. 7.18.3 Novogene Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Novogene Genome Sequencing Service Product Portfolio
  108. 7.18.5 Novogene Recent Developments
  109. 7.19 Eurofins Genomics
  110. 7.19.1 Eurofins Genomics Company Information
  111. 7.19.2 Eurofins Genomics Business Overview
  112. 7.19.3 Eurofins Genomics Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Eurofins Genomics Genome Sequencing Service Product Portfolio
  114. 7.19.5 Eurofins Genomics Recent Developments
  115. 7.20 Psomagen
  116. 7.20.1 Psomagen Company Information
  117. 7.20.2 Psomagen Business Overview
  118. 7.20.3 Psomagen Genome Sequencing Service Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Psomagen Genome Sequencing Service Product Portfolio
  120. 7.20.5 Psomagen Recent Developments
8 North America
  1. 8.1 North America Genome Sequencing Service Revenue (2021-2032)
  2. 8.2 North America Genome Sequencing Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Genome Sequencing Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Genome Sequencing Service Revenue by Type (2027-2032)
  5. 8.3 North America Genome Sequencing Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Genome Sequencing Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Genome Sequencing Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Genome Sequencing Service Revenue by Application (2027-2032)
  9. 8.5 North America Genome Sequencing Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Genome Sequencing Service Revenue by Country
  11. 8.6.1 North America Genome Sequencing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Genome Sequencing Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Genome Sequencing Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Genome Sequencing Service Revenue (2021-2032)
  2. 9.2 Europe Genome Sequencing Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Genome Sequencing Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Genome Sequencing Service Revenue by Type (2027-2032)
  5. 9.3 Europe Genome Sequencing Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Genome Sequencing Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Genome Sequencing Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Genome Sequencing Service Revenue by Application (2027-2032)
  9. 9.5 Europe Genome Sequencing Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Genome Sequencing Service Revenue by Country
  11. 9.6.1 Europe Genome Sequencing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Genome Sequencing Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Genome Sequencing Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Genome Sequencing Service Revenue (2021-2032)
  2. 10.2 China Genome Sequencing Service Revenue by Type (2021-2032)
  3. 10.2.1 China Genome Sequencing Service Revenue by Type (2021-2026)
  4. 10.2.2 China Genome Sequencing Service Revenue by Type (2027-2032)
  5. 10.3 China Genome Sequencing Service Revenue Share by Type (2021-2032)
  6. 10.4 China Genome Sequencing Service Revenue by Application (2021-2032)
  7. 10.4.1 China Genome Sequencing Service Revenue by Application (2021-2026)
  8. 10.4.2 China Genome Sequencing Service Revenue by Application (2027-2032)
  9. 10.5 China Genome Sequencing Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Genome Sequencing Service Revenue (2021-2032)
  2. 11.2 Asia Genome Sequencing Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Genome Sequencing Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Genome Sequencing Service Revenue by Type (2027-2032)
  5. 11.3 Asia Genome Sequencing Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Genome Sequencing Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Genome Sequencing Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Genome Sequencing Service Revenue by Application (2027-2032)
  9. 11.5 Asia Genome Sequencing Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Genome Sequencing Service Revenue by Country
  11. 11.6.1 Asia Genome Sequencing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Genome Sequencing Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Genome Sequencing Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Genome Sequencing Service Revenue (2021-2032)
  2. 12.2 SAMEA Genome Sequencing Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Genome Sequencing Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Genome Sequencing Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Genome Sequencing Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Genome Sequencing Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Genome Sequencing Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Genome Sequencing Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Genome Sequencing Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Genome Sequencing Service Revenue by Country
  11. 12.6.1 SAMEA Genome Sequencing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Genome Sequencing Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Genome Sequencing Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research